Unicycive Grants Director Meredith Manning 27,000 Stock Options
Bitget2026/10/29 20:46- Unicycive Therapeutics granted director Meredith Manning 3,350 restricted stock units on Oct. 28, 2026.
- Manning also received 27,000 stock options with an exercise price of $3.76.
- The options become exercisable Oct. 28, 2027, and expire Oct. 28, 2036.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley: AI capital expenditure may reach 10 to 15 trillions USD in the next 10 years
Morgan Stanley stated that capital expenditure in the artificial intelligence (AI) sector could reach $10-15 trillions over the next decade.

Morgan Stanley: Apple's target price lowered to $350

Autoliv completes acquisition of MCF Safety Belts
Refining profits surge and oil prices soar; Saudi Aramco Q3 profits grow by 9% and maintains a dividend of 21.9 billions USD.
Driven by rising refining profits and oil prices, Saudi Aramco's third-quarter profits increased by 9%.